Deignan Charles A.

Avg. Two Year Performance

21% Avg. Purchase Return
10% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return13%28%(11%)14%21%
Purchase Success Rate2 of 42 of 41 of 43 of 41 of 4
Average Sale Return(3%)4%(2%)0%0%
Sale Success Rate0 of 31 of 30 of 30 of 30 of 3

Clearside Biomedical, Inc.

Other » Other

Chief Financial Officer:

Holdings: 384.66K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--